Friday, January 21, 2022

Moderna vaccine

Pfizer, Moderna vaccines cut COVID-19 risk by 91 per cent: Study

The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.

Editorial: Expand the vaccine basket

The Centre must speed up negotiations with foreign companies towards the removal of stumbling blocks to expand coverage

Pfizer, Moderna vaccines cut infection risk by 91%: US CDC

Even a single dose of the mRNA vaccines can reduce the risk of infection by 81 per cent. These estimates included symptomatic and asymptomatic infections.

Pfizer, Moderna refuse to sell vaccines to Delhi govt directly: CM Kejriwal

The vaccine manufacturers have said that they will deal with the Government of India alone, Kejriwal added.

Moderna vaccine has more side effects that Pfizer/BioNTech: Study

Nearly 51 per cent of Moderna recipients had full-body symptoms, compared with 48 per cent of people who got the Pfizer/BioNTech shot.

Woman gives birth to first known baby with antibodies against coronavirus

The woman, who has been breastfeeding the baby exclusively, received the second dose of the vaccine as per the normal 28-day vaccination protocol timeline.

Pfizer, Moderna vaccines may reduce risk of asymptomatic COVID-19 infection

The Pfizer-BioNTech and Moderna messenger RNA (mRNA) vaccines for COVID-19 are authorised for emergency use in many countries.

UN chief Antonio Guterres receives COVID-19 vaccine

In December last year, Guterres had said he intended to take the COVID-19 vaccine when it became available and that he would do so “publicly”.

US Vice President Kamala Harris receives Covid-19 vaccine

According to the Biden-Harris transition team, Harris was vaccinated on Tuesday by Patricia Cummings, a clinical nurse manager at the United Medical Center.

Moderna vaccine set for imminent US approval, as Europe battles surge

The European Union is under massive pressure to approve potential vaccines after Britain and the United States began rolling out a drug produced by Pfizer and BioNtech.

Moderna plans 100 million Covid vaccine doses in early 2021

Moderna also confirmed that it expects to have 20 million vaccine doses available in the US by the end of 2020.

New vaccine breakthrough lifts global hope against pandemic

Moderna, whose results stem from a clinical trial of more than 30,000 participants, expects to have approximately 20 million doses ready to ship in the United States by year-end.

Latest News

- Advertisement -